Viruses are the most numerous biological entities on the planet. Now researchers at the Wellcome Sanger Institute and EMBL’s European Bioinformatics Institute (EMBL-EBI) have identified over 140,000 viral species...
A new study in human and mouse cell lines shows that specific proteins that have long been studied as inhibitors of influenza can also inhibit SARS-CoV-2, the type of coronavirus that causes COVID-19. Findings of the...
Of all the Covid-19 vaccine candidates making their way through the regulatory pipeline, the two from Pfizer/BioNTech and Moderna are some of the most exciting. In addition to having reported efficacies of 90% of more...
In a multi-group collaborative involving the National Emerging Infectious Disease Laboratories (NEIDL), the Center for Regenerative Medicine (CReM), and the Center for Network Systems Biology (CNSB), scientists have...
As the world awaits the imminent arrival of one — or several — COVID-19 vaccines, many people may wonder how important vaccines actually are to safeguarding public health. In this feature, we answer that question by...
Fewer than three quarters of people around the world say they are likely to use a vaccination against COVID-19 if one is approved by regulatory agencies, falling short of the levels required to achieve collective...
How can we battle these infectious agents such as Ebola virus disease (EVD) that reproduce by hijacking cells and reprogramming them into virus-replicating machines? A research team led by Professor Juan Perilla at the...
Whether flu or coronavirus, it can take several days for the body to ramp up an effective response to a viral infection. New research appearing in the journal Nature Immunology describes how different cells in the...
Three-quarters of emerging illnesses come from animals and a new report identifies climate change as a primary driver of many of them. As the new coronavirus continues to turn the world upside down, crashing economies...
Responding to a need to quickly develop billions of doses of lifesaving COVID-19 vaccines, a scientific team at The University of Texas at Austin has successfully redesigned a key protein from the coronavirus, and the...